Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Patients with psoriasis more likely to commit suicide

13 Sep 2017

The likelihood of suicidal ideation, suicide attempts and completed suicides is substantially greater in patients with psoriasis, according to a recent study. Among these patients, those who are younger and whose psoriasis is more severe are at risk of suicidality.

Researchers conducted a systematic review and meta-analysis to further understand the relationship between psoriasis and suicidality. The databases of PubMed, Embase, PsycINFO and Cochrane were systematically searched for literature published between 1946 and 2017.

A total of 18 studies were included. This involved 1,767,583 participants, of whom 330,207 had psoriasis.

Based on random effects modelling, suicidal ideation among patients with psoriasis had a pooled odds ratio (OR) of 2.05 (95 percent CI, 1.54 to 2.74). These patients were more likely to attempt suicides (OR, 1.32; 1.14 to 1.54) and complete suicide (OR, 1.20; 1.04 to 1.39) than those without psoriasis.

The factors associated with higher possibility of suicidality were younger age and more severe psoriasis.

“There are few studies examining suicidality in conjunction with psoriasis severity,” researchers said.

In another study, Chi and colleagues found no association between psoriasis and suicidal thought and behaviour. They found no increase in the risk of suicide (risk ratio [RR], 1.13; 0.87 to 1.46), suicide attempt (RR, 1.25; 0.89 to 1.75) or suicidality (RR, 1.26; 0.97 to 1.64) among patients with psoriasis. Their stratified analysis also revealed no increase in suicide, suicide attempt and suicidality among those with either mild or severe psoriasis. [Am J Clin Dermatol 2017;doi:10.1007/s40257-017-0281-1]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.